全球霉浆菌测试市场：按产品类型、按应用、按最终用户、按地区

全球霉浆菌检测市场规模预计将从 2024 年的 9.978 亿美元增至 2031 年的 19.076 亿美元，预测期内复合年增长率为 9.7%。

图 1. 2024 年霉浆菌检测全球市场占有率(%)（按地区）

霉浆菌检测在生物技术和製药领域至关重要。市面上有不同类型的霉浆菌检测产品。我们的主要产品可分为两类：套件和服务。

套件是一个自足式的工具，可让研究人员自行测试霉浆菌污染。这些套件包含测试所需的所有试剂和说明。最常见的套件类型是基于聚合酵素链锁反应(PCR) 的套件、基于酵素结合免疫吸附检测法(ELISA) 的套件和基于微生物学的套件。 PCR套件灵敏且特异性，但需要专门的设备。 ELISA套件易于使用，因为它们不需要专门的设备，但其灵敏度不如 PCR。微生物套件可直接检测霉浆菌生长情况，但结果需要时间。

除了套件之外，许多公司还提供霉浆菌检测服务，研究人员将样本送到专门的检测机构。该服务的优点是研究人员无需投资设备或培训。我们的服务机构经验丰富的技术人员可以进行各种类型的测试，包括 PCR、ELISA 和微生物检测，并提供报告。然而，结果可能需要一些时间，因为必须运送样品。套件可以加快测试速度，但需要适当的基础设施。两种产品在不同情况下各有优势，取决于各个实验室的要求和能力。

市场动态：

市场参与者对研发（R＆D）活动的​​开拓预计将在预测期内推动市场成长。此外，市场参与企业增加有机和无机策略将促进预测期内的市场成长。

本研究的主要特点

• 本报告对全球霉浆菌检测市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
• 它还阐明了不同细分市场的潜在收益成长机会，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球霉浆菌测试市场的主要企业。
• 该报告的见解使行销人员和公司负责人能够就未来的经营团队发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球霉浆菌测试市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球霉浆菌检测市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 市场相关人员活性化研发活动
  • 研发费用增加
• 主要亮点
• 监管场景
• 最近的趋势
• PEST分析
• 波特的分析
• 合併、收购和合作

第四章全球霉浆菌检测市场 -冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球霉浆菌检测市场，依产品类型，2019-2031

• 套件和试剂
• 装置

第六章 全球霉浆菌检测市场，依应用分类，2019-2031

• 细胞株测试
• 病毒检测
• 成品检验
• 其他（原料检验等）

第七章 全球霉浆菌检测市场，依最终用户划分，2019-2031

• 製药和生物技术公司
• 合约研究组织
• 学术研究所

第八章2019-2031年全球霉浆菌检测市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章 竞争形势

• 公司简介
  • Charles River Laboratories International
  • Merck KGaA
  • Lonza Group Ltd
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Merck
  • InvivoGen
  • Creative Bioarray
  • Other Prominent Players

第10章

• 参考
• 调查方法
• 关于出版商

Global mycoplasma testing market size is expected to reach US$ 1,907.6 Mn by 2031, from US$ 997.8 Mn in 2024, exhibiting a compound annual growth rate (CAGR) of 9.7% during the forecast period.

Figure 1. Global Mycoplasma Testing Market Share (%), By Region, 2024

Mycoplasma testing is essential in the field of biotechnology and pharmaceuticals. There are different types of products available in the market for mycoplasma testing. The major products can be categorized into two types - kits and services.

Kits are self-contained tools that allow researchers to test for mycoplasma contamination on their own. These kits have all the necessary reagents and instructions to perform the test. The most common types of kits are polymerase chain reaction (PCR)-based kits, enzyme-linked immunosorbent assay (ELISA) based kits, and microbiological-based kits. PCR kits are highly sensitive and specific but require specialized equipment. ELISA kits are easier to use as they don't need specialized equipment but are less sensitive than PCR. Microbiological kits involve detecting mycoplasma growth directly but take longer time to give results.

Along with kits, various companies offer mycoplasma testing as services where researchers can send their samples to specialized testing facilities. The advantage of services is that researchers do not need to invest in equipment or training. Experienced technicians at the service facilities perform different types of tests like PCR, ELISA, and microbiological assays and provide reports. However, there can be delays in getting results as samples need to be shipped. Kits allow for faster testing but require proper infrastructure. Both products have their advantages in different situations depending on individual lab requirements and capacities.

Market Dynamics:

Growing research and development (R&D) activities by the market players is expected drive the market growth over the forecast period. Moreover, increasing organic and inorganic strategies by the market players will aid in the market growth over the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global mycoplasma testing market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mycoplasma testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Charles River Laboratories International, Merck KGaA, Lonza Group Ltd, Roche Diagnostics, Thermo Fisher Scientific, Merck, InvivoGen, Creative Bioarray, and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global mycoplasma testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mycoplasma testing market

Detailed Segmentation:

• Global Mycoplasma Testing Market, By Product Type
  • Kits & Reagents
  • Instruments
• Global Mycoplasma Testing Market, By Application
  • Cell Line Testing
  • Virus Testing
  • End of Production Testing
  • Others (Raw Material Testing, etc.)
• Global Mycoplasma Testing Market, By End User
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
• Global Mycoplasma Testing Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Top Companies in the Global Mycoplasma Testing Market:
  • Charles River Laboratories International.
  • Merck KGaA
  • Lonza Group Ltd
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Merck
  • InvivoGen
  • Creative Bioarray
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising research and development activities by the market players
  • Increasing R&D Expenditure
• Key Highlights
• Regulatory Scenario
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Mycoplasma Testing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Mycoplasma Testing Market, By Product Type, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, 2020- 2031
  • Segment Trends
• Kits & Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Mycoplasma Testing Market, By Application, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cell Line Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Virus Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• End of Production Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Others (Raw Material Testing, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Mycoplasma Testing Market, By End User, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Academic Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Mycoplasma Testing Market, By Region, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031(%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profile
  • Charles River Laboratories International
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Merck KGaA
  • Lonza Group Ltd
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Merck
  • InvivoGen
  • Creative Bioarray
  • Other Prominent Players
• Analyst Views

10. Section

• References
• Research Methodology
• About us